Skip to main content
Publications
Pisa F, Castellsague J, Drigo D, Riera Guardia N , Giangreco M, Rosolen V, Clagnan E, Zanier L, Perez-Gutthann S , Barbone F. Accuracy of ICD-9-CM codes for upper gastrointestinal complications vaired by position and age: a validation study in a cohort of NSAID users in Friuli Venezia Giulia, Italy . Pharmacoepidemiol Drug Saf. 2013 Nov 22;22(11):1195-204. doi: 10.1002/pds.3504
Toh S, Avorn J, D'Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ , Saag KG, Sturkenboom MCJM, Vandenbroucke JP, Winterstein AG, Strom BL. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs . Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1036-45.
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD , Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research . Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y
Esposito DB, Lensen L, Eisenberg DF, Grant A, Hawes JCL, Holick CN, Ke X, Luthra R, Maloney J, Mehta V, Mines D . Background rates of anaphylaxis in general and allergic populations . Poster presented at the 2013 29th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2013. Montreal, Quebec. [abstract] Pharmacoepidemiol Drug Saf. 2013 Oct; 22(Suppl 1):397.
Pisa F, Castellsague J, Drigo D, Riera-Guardia N , Giangreco M, Rosolen V, Clagnan E, Zanier L, Perez-Gutthann S , Barbone F. Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy . Pharmacoepidemiol Drug Saf. 2013 Aug 20;22(11):1195-204.
Castellsague J, Pisa F, Rosolen V, Drigo D, Riera Guardia N , Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S . Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy . Pharmacoepidemiol Drug Saf. 2013 Apr 22;22(4):365-75.
Kaye JA, Castellsague J, Bui C , Calingaert B , McQuay LJ, Riera N , Saltus C , Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander MA, Perez-Gutthann S . Risk of acute liver injury in a cohort of oral antimicrobial users . Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Supp 3):92. doi: 10.1002/phar.1367
Afonso A, Prieto-Alhambra D, Escudero Garcia A, Estany Gestal A, Martin-Merino E, Riera Guardia N , Lopez-Leon S, Perez-Gutthann S , Hernández-Díaz S. FarmacoEpiEnRed, a network for pharmacoepidemiology in Spain . Poster presented at the 28th International Conference on Pharmacoepidemiology; August 27, 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug 27; 21(Suppl 3):193. doi: 10.1002/pds.3324
Alonso-Espinaco V, Marmol M, Alonso V, Escudero P, Horndler C, Ortego J, Gallego R, Garcia-Albeniz X , Jares P, Cuatrecasas M, Jose Lozano J, Castells A, Maurel J. Influence of BRAF mutations and RAC1b/RAC1 mRNA expression ratio on outcome in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy . Poster presented at the 2012 ASCO Annual Meeting; June 4, 2012. Chicago, IL. [abstract] J Clin Oncol. 2012 Jun; 30(15_Suppl):3553. doi: 10.1200/jco.2012.30.15_suppl.3553
Kiladjian J-J, Gisslinger H, Passamonti F, Niederwieser D, Mendelson E, Sirulnik LA, Copley-Merriman K , Zhou X , Levy RS, Knoops L, Cervantes F, Barbui T, Barosi G, Vannucchi AM, Harrison CN. Health-related quality of life (HRQoL) and symptom burden in patients (Pts) with myelofibrosis (MF) in the COMFORT-II study . Poster presented at the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO); June 1, 2012. Chicago, IL. [abstract] J Clin Oncol. 2012 Jun 1; 30(15_suppl):6626. doi: 10.1200/jco.2012.30.15_suppl.6626